Core Medical Technology
Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
VelaVigo
Seed Round in 2024
VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
X Square
Seed Round in 2024
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Juntong Future
Seed Round in 2024
Juntong Future is an artificial intelligence and digital intelligence security service provider that focuses on the governance and compliance challenges of artificial intelligence itself
PulseCare
Series A in 2024
PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
Reju Therapeutics
Seed Round in 2024
Reju Therapeutics, a biopharmaceutical company, is dedicated to research and development of drugs for treating degenerative diseases like neurodegenerative, fibrotic, and inflammatory conditions.
Yitai Microelectronics
Seed Round in 2024
Yitai Microelectronics is an automotive Ethernet chip developer company that specializes on producing high-performance, high-reliability, and low-power automotive Ethernet communication chips and systems.
Rokae
Venture Round in 2024
Rokae is a manufacturer specializing in the research, development, and production of lightweight industrial robots and robot control systems. The company is dedicated to enhancing industrial automation by offering high-performance robotic products and interactive control systems. Its solutions are utilized across various sectors, including computing, communications, consumer electronics, textiles, food, medicine, and automotive manufacturing. Rokae aims to add value for high-end manufacturing clients through its commitment to independent research and development, focusing on both robot hardware and integrated application solutions.
Akaso Bio
Seed Round in 2024
Akaso Bio is a leader in 3D microfluidic chip technology, dedicated to exploring and expanding new applications of high-throughput microfluidic technology, and becoming an innovative solution provider for high-performance microsphere products.
Daoyi Semiconductor
Seed Round in 2024
Daoyi Semiconductor is a company that specializes in the research and development, manufacturing, sales, and technical support of epoxy plastic encapsulating materials for various semiconductor devices, integrated circuits, power modules, and other electronic packaging.
Pai Rui Semiconductor
Seed Round in 2023
Pai Rui Semiconductor is an integrated circuit design specialist with a focus on high-performance mixed-signal technology. Its main objective is to aid in the quantification of analog signals by use of sub-gate and ultra-high-precision differential delay chains that are independently created.
Jingfei Semiconductor
Angel Round in 2023
Jingfei Semiconductor manufactures semiconductor laser processing equipment. It is primarily concerned with the design, development, and manufacture of laser-related equipment and processes in the semiconductor industry.
Aikai Biotech is focused on developing a new generation of off-the-shelf general-purpose cell therapy pharmaceuticals using iPSC.
Tree Industrial Manufacturing
Series A in 2023
Hunan Tree Industrial Manufacturing is a company that focuses on the production of advanced robotic machinery specifically designed for high-tech manufacturing environments. The company specializes in automatic robots and equipment used for various processes, including casting, sanding, and polishing. By offering compatible automatic grinding machines, Tree Industrial Manufacturing enables users to integrate their technology into a variety of factory settings, enhancing efficiency and precision in manufacturing operations.
Yaoshi Medical
Series A in 2023
Yaoshi Medical conducts research and development in the field of ocular illness diagnosis and screening equipment.
Dify.AI
Seed Round in 2023
Dify is an open-source LLM app development platform. Dify's intuitive interface combines AI workflow, RAG pipeline, agent capabilities, model management, observability features and more, letting you quickly go from prototype to production.
D2M Biotherapeutics
Series A in 2023
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.
Qinglian Biotech
Series A in 2023
Qinglian Biotech is an innovative proteomics detection technology service provider.
D2M Biotherapeutics
Series A in 2022
D2M Biotherapeutics focuses on the development of novel immunotherapeutics. The company is a tumor immunological drug developer that aims to expand the potential of immunotherapy.
Macrotest
Venture Round in 2022
Macrotest is a company focused on the research, development, testing, and marketing of semiconductor equipment. It specializes in creating integrated circuit testing equipment, including high-speed digital, high-voltage high-current analog, mixed-signal, and RF integrated circuits. Additionally, Macrotest develops automated test equipment (ATE) and various test boards, offering comprehensive back-end solutions for the semiconductor industry. The company holds multiple domestic patents and trademarks for its software and hardware innovations, reinforcing its commitment to advancing technology in the semiconductor sector.
Juexin Technology
Seed Round in 2022
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.
Redbud Medicine
Series A in 2022
Redbud Medicine is a company that specializes in clinical trial services for the pharmaceutical and biotechnology industries. It focuses on real-time data analysis to enhance innovation and streamline clinical development processes. By providing efficient services, Redbud Medicine helps biotechnology companies in China and globally to optimize and accelerate their clinical trials, thereby reducing operational costs and expediting the study process. The company also assists local Chinese biotechnology firms in introducing their products to the global market, while supporting foreign biotechnology companies in navigating the Chinese market.
Trinova Technology
Series B in 2022
Trinova Technology specializes in the production and technical services of intelligent automotive wire-controlled chassis systems. The company is at the forefront of developing advanced safety technologies and electronic control systems for vehicles in China. Trinova has created a range of sophisticated products, including redundant electronically controlled steering, eBooster, and integrated braking and stability systems. Their focus encompasses critical components such as automatic emergency braking, lane-keeping assistance, and advanced driver assistance systems. Trinova's capabilities extend across the entire research and development spectrum, including testing, manufacturing, calibration, and integration of automotive chassis electronic control products, positioning the company as a key player in the autonomous driving sector.
Mech-Mind Robotics
Series C in 2022
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.
Zhongqu Technology
Series B in 2022
Zhongqu (Beijing) Technology Co., Ltd. is a company that specializes in the development of 3D scanning camera technology. Founded in 2014, it is located in Beijing, China. The company focuses on creating innovative solutions in the field of 3D scanning, catering to various applications and industries.
AIForceTech
Series A in 2022
AIForceTech is a Beijing-based company founded in 2019 that focuses on agricultural robotics and smart machinery. It specializes in the research, development, and manufacturing of robotic products designed to enhance efficiency in the agriculture sector. The company is advancing the deployment of unmanned pure electric tractors and a range of electric-powered agricultural robots. These innovative solutions leverage artificial intelligence and autonomous driving technology, allowing tractors to operate without human intervention both day and night. AIForceTech's products are actively utilized in real-world agricultural scenarios, providing the company with valuable practical insights and experience in the field.
Immunofoco
Seed Round in 2022
Immunofoco is a biotechnology company focused on developing immune cell drugs specifically designed for patients with solid tumors. The company aims to revolutionize cancer treatment by transforming solid tumors into hematological tumors, thereby applying innovative therapeutic strategies that leverage the clinical advantages of treating hematologic malignancies. Immunofoco has introduced the first CAR-T (chimeric antigen receptor) product to the Chinese market and has pioneered a clinical approach that offers potential long-term survival benefits for patients facing the challenges of solid tumor treatment. Through its groundbreaking research and development, Immunofoco is committed to providing novel drug therapies that enhance the effectiveness of tumor management.
Hesguard
Seed Round in 2021
Hesguard is a medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases.
Yuneng Technology
Series A in 2021
Yuneng Technology specializes in the research and development of advanced soft magnetic materials, primarily aimed at enhancing battery performance and wireless charging efficiency. The company focuses on nanocrystalline material formulations and innovative magnetic isolation sheet processes. These technologies enable improved charging power and efficiency, catering to clients across various sectors, including consumer electronics, new energy vehicles, and the photovoltaic industry. By providing powerful and efficient magnetic materials, Yuneng Technology supports the advancement of electronics and energy solutions.
Yuntian Semiconductor
Series B in 2021
Yuntian Semiconductor is a semiconductor firm that develops TGV technology, filter wafer-level 3-D packaging technology, and IPD technology.
Lips Semiconductor
Series A in 2021
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.
Danwang Medical
Series A in 2021
Danwang Medical provides clinical transformation technology services to regenerative medicine for disease diagnosis and treatments. They also provide organoid drug sensitivity testing, organoid disease models, organoid drug development, and organoid chips. Danwang Medical is committed to applying the most recent clinical transformation technology of regenerative medicine to disease diagnosis and treatment, new drug screening, tumor marker development and identification, and other areas in order to provide clinical personalized treatment technology and accurate, efficient, and high-quality organoids Model to new drug research and development enterprises.
CalmCar Vision System
Series C in 2021
CalmCar Vehicle Vision is a Chinese intelligent driving vision system provider. They are specialized in developing intelligent vision system for ADAS, autopilot and autonomous driving with functions of Lane Departure Warning (LDW), Front Collision Warning (FCW), Pedestrian Collision Warning(PCW), Blind Spot Detection (BSD) and Traffic Sign Recognition (TSR).
xMEMS is a company founded in 2018 and based in Santa Clara, California, that specializes in developing advanced audio solutions for consumer electronics. The company focuses on innovative speaker technology designed to meet the growing demands for improved audio quality and longer battery life in in-ear personal audio devices. By utilizing a monolithic semiconductor process, xMEMS offers a high-precision alternative to traditional speaker technologies, such as dynamic and balanced armature drivers. This approach enhances audio fidelity while optimizing size and energy consumption, allowing manufacturers to replace outdated, manually-assembled components with more consistent and efficient solutions.
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
AIForceTech
Series A in 2021
AIForceTech is a Beijing-based company founded in 2019 that focuses on agricultural robotics and smart machinery. It specializes in the research, development, and manufacturing of robotic products designed to enhance efficiency in the agriculture sector. The company is advancing the deployment of unmanned pure electric tractors and a range of electric-powered agricultural robots. These innovative solutions leverage artificial intelligence and autonomous driving technology, allowing tractors to operate without human intervention both day and night. AIForceTech's products are actively utilized in real-world agricultural scenarios, providing the company with valuable practical insights and experience in the field.
Hong Jing Drive
Series A in 2021
Hong Jing Drive is a full-stack autonomous driving solution provider based in Hangzhou, Zhejiang. Established on May 2, 2018, by Feilong Liu, the company specializes in the development and integration of software and hardware for autonomous driving systems. Its offerings include an automatic driving computing platform, sensor selection and layout, as well as comprehensive software system integration and calibration. Hong Jing Drive aims to deliver safe and efficient autonomous transportation solutions to consumers, positioning itself as a significant player in the autonomous driving industry.
ETHA Labs is a community-driven incubator dedicated to fostering innovation in the Decentralized Finance (DeFi) sector. The company aims to lower entry barriers for both institutional and retail users to promote mass adoption of DeFi solutions. Its ecosystem is structured into two main components: ETHA Lab (Build), which focuses on developing essential infrastructure and tools for DeFi, and ETHA Lab (Incubate), which nurtures new innovations and external DAO-based DeFi projects. Additionally, ETHA serves as a protocol-agnostic yield optimizer that utilizes Ethereum and Polkadot technologies to provide algorithmically optimal yields across various platforms. A significant feature of the platform is ETHA Lend, which is designed to maximize returns from DeFi liquidity pools while supporting a wide variety of digital assets. By simplifying access and reducing complexity, ETHA Labs seeks to empower users in optimizing their DeFi investments, with governance and operational functions facilitated by its native token.
Zhishan Weixin Biotechnology
Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Tapdata
Seed Round in 2021
Tapdata is a software company specializing in real-time data integration and enterprise data management solutions. The company offers a platform powered by MongoDB and Elastic Search, aimed at serving the online transaction processing (OLTP) business sector in China. Tapdata's services include data as a service (DaaS) and software as a service (SaaS), designed to eliminate data silos and create a unified data layer for organizations. This enables enterprises to efficiently access, analyze, and innovate with their data, facilitating the rapid establishment of real-time data centers and supporting data processing and synchronization in real time.
Polaris Biology
Series B in 2020
Polaris Biology is a medical technology company focused on the development and application of cell-level precision diagnostic technology aimed at enhancing tumor diagnosis and treatment. The company employs advanced artificial intelligence algorithms and drug-system biological models to deliver accurate and direct clinical support for cancer treatment. By investigating individual and dynamic changes in tumors at the cellular level, Polaris Biology provides innovative diagnostic tools that assist both patients and healthcare professionals in making informed decisions regarding cancer care.
Sophonix is a company specializing in the development, production, and sales of in vitro diagnostic instruments and reagents. It focuses on providing accurate point-of-care testing (POCT) solutions, offering products such as automatic chemiluminescence immunoanalyzers and ultra-path automatic immunohistochemically staining apparatus. The company aims to deliver highly sensitive and accurate testing results to assist medical professionals in making precise diagnoses.
YEESTOR Microelectronics Co., Ltd specializes in the development and sale of memory control chips, focusing primarily on storage controllers. Established in 2007 and headquartered in Shenzhen, China, the company provides a range of products including PCIe SSD controllers, SATA SSD controllers, UFS controllers, eMMC controllers, USB controllers, and security storage controllers. These products are used across various applications, such as data centers, servers, personal computers, smartphones, tablets, smart homes, and the Internet of Things. YEESTOR serves clients that include storage IC companies and module manufacturers, offering technical support and customized solutions to enhance design efficiency and reliability. The company emerged from the merger of SiliconGo Microelectronics and Auspitek and has achieved significant milestones, including cumulative shipments exceeding 700 million units, positioning itself as a leading global supplier in the flash memory controller market.
Fit2Cloud
Series C in 2020
Fit2Cloud, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers across various multi-cloud environments. Fit2Cloud's offerings address critical issues related to IT operation security and continuous application delivery. Their product lineup includes a comprehensive Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these solutions, Fit2Cloud empowers enterprises to effectively manage and utilize cloud services, facilitating their digital transformation and ensuring a seamless operational experience.
Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, focused on developing antibody therapeutics for cancer treatment. Established in 2010, Apexigen specializes in immuno-oncology, creating therapies that aim to leverage the patient's immune system to effectively combat and eradicate cancer. The company's pipeline includes several promising candidates, such as APX005M and APX201 for immuno-oncology, along with additional programs targeting various oncology and inflammation conditions. Notably, its lead candidate, sotigalimab, is currently in clinical development, complemented by a range of preclinical immuno-oncology programs. Apexigen also utilizes its proprietary APXiMAB platform to discover novel antibodies targeting immune system pathways, underscoring its commitment to advancing innovative treatments in cancer care.
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering and developing innovative protein and peptide therapeutics aimed at treating cancer. The company employs several proprietary platforms, including XTEN for extending drug half-life, XPAT for analyzing protease activity in the tumor microenvironment, and ProTIA, which focuses on immuno-oncology therapeutics. Amunix's product pipeline includes prodrugs and transformative T-cell engagers designed to activate the immune system against solid tumors. The company collaborates with various academic, biotechnology, and pharmaceutical sectors, maintaining strategic partnerships with organizations such as Janssen and Biogen-Idec. Founded in 2006 and headquartered in Mountain View, California, Amunix strives to deliver breakthroughs that can harness the immune system to combat cancer more effectively.
Barrot is a company that specializes in the development and manufacture of wireless Bluetooth technologies. They produce Bluetooth chips and modules tailored for various applications, including automobiles, smart homes, wireless audio devices, wireless printers, and intelligent manufacturing systems. Barrot's products enable companies and manufacturers to integrate advanced wireless technology into their offerings.
Hummingbird Bioscience
Series B in 2019
Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.
SeekGene
Seed Round in 2019
SeekGene is a company specializing in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. With a team that possesses extensive research and clinical service experience, SeekGene aims to apply single-cell sequencing technology to real-world clinical research effectively. The company has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, simplicity, and cost-effectiveness. This innovative kit is designed to facilitate the clinical transformation of single-cell sequencing technology, enabling better understanding of immune responses at the single-cell level. By focusing on technologies related to T cell receptor and peptide-bound major histocompatibility complex pairing, SeekGene supports clinical and drug research as well as disease monitoring and treatment efforts.
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.
Lemon Photonics
Series A in 2019
LEMON Photonics Technologies Co. Ltd. is a high-tech company based in Shenzhen, China, founded in 2018 by a team of experienced laser professionals and venture capitalists. The company specializes in the research, development, sale, and industrialization of semiconductor electro-optical devices, modules, and systems. It offers a range of products, including low-power direct diode lasers, fiber-coupled diode lasers, and high-power direct diode lasers, catering to various industrial applications. LEMON Photonics is committed to advancing laser technology through its innovative solutions in the electro-optical sector.
Rinfon specializes in the research, development, production, sales, and service of communication products for satellites and unmanned aerial vehicles (UAVs). The company is a leading provider of satellite signals and modules, as well as comprehensive systems and solutions tailored for satellite and drone applications. Rinfon's offerings primarily emphasize wireless communication systems, delivering innovative products and overall wireless communication test solutions that enhance the capabilities of unmanned platforms. Through its focus on advanced communication technologies, Rinfon aims to meet the evolving needs of its customers in the aerospace and telecommunications sectors.
KnowBox is a company established in 2014 that focuses on the K12 education sector, offering two mobile apps designed to enhance the homework experience for students and teachers. These apps provide personalized exercises that cater to individual learning needs, while also allowing teachers to manage student assignments more efficiently. By reducing repetitive tasks, the platform enables educators to dedicate more time to addressing the unique challenges of each student. With nearly one million daily active users, KnowBox is committed to further developing its services, including the creation of a comprehensive homework database to enrich its educational offerings.
Guofu Hydrogen
Series A in 2019
Furui Hydrogen was started by Furui Special Equipment Co. Ltd, a listed public company (stock 300338.sz) in China with market value of 3.8 billion RMB. Furui Special Equipment is a leader in LNG equipment market, and is credited with building up the LNG-transportation market in China. Furui Hydrogen aims to build up the hydrogen-for-mobility industry in China. Furui Hydrogen is a leader in the infrastructure equipment sector focused on heavy equipment for hydrogen fueling stations, on-vehicle hydrogen tanks and hydrogen liquefaction equipment. Furui Hydrogen targets three markets: Hydrogen filling station equipment, FCV hydrogen supply system and H2 liquifying system.
Panorama Medicine
Seed Round in 2019
Panorama Medicine, Inc. is a biotechnology company that specializes in developing a drug discovery platform aimed at addressing RNA defects associated with various diseases. Founded in 2018 by Mingfu Zhu, the company is headquartered in Bala Cynwyd, Pennsylvania. Its platform combines genomics, big data, and artificial intelligence to facilitate drug screening and the development of therapeutic interventions. By integrating these advanced technologies, Panorama Medicine enables medical researchers and companies to effectively identify and target genetically-defined diseases, particularly those that can be treated through the modulation of RNA splicing.
Archiwave Micro
Series A in 2019
Anqiwei Microelectronics was incorporated in July 2015 to focus on the development of high-performance RF microwave integrated circuits and module products based on silicon germanium SiGe BiCMOS, silicon-on-insulator SOI-CMOS and bulk silicon CMOS processes. Dr. Lu Jianhua, the founder of the company, received his Ph.D. from the University of California, Los Angeles (UCLA) and has been involved in RF and microwave integrated circuit design and product development in California. His products have won the ECN Impact Award. And Microwave Journal Best Product, and published the IEEE JSSC paper and several US patents as the first author. Several other core co-founders are top RF RF chip and system experts in the country and have accumulated decades of industry experience.
Recida Therapeutics
Series A in 2019
Recida Therapeutics is a biotechnology company focused on developing innovative antibiotic drugs aimed at treating serious antibiotic-resistant infections. The company specializes in creating novel-class antibiotics that target the increasing challenge posed by multi-drug resistant gram-negative bacteria. Through its research and development efforts, Recida Therapeutics seeks to provide effective therapeutics that enable patients to combat potentially deadly pathogens, addressing a critical need in the healthcare landscape.
DFocus Intelligent Technology Co., Ltd., founded in 2015 and headquartered in Shanghai, China, specializes in cloud-based software solutions for workspace planning and management. The company is a leader in smart space and smart building management, utilizing Internet of Things (IoT) technology, high-precision sensors, and big data analytics to enhance workspace efficiency and reduce costs for enterprises. DFocus serves over 200 clients, including nearly 100 Fortune Global 500 companies such as Microsoft, Huawei, and Alibaba. Additionally, the company collaborates with notable organizations and institutions, including Tongji University and Gensler, to establish industry standards and practices, further solidifying its position as a key player in the real estate sector.
Majorsec is an enterprise-level cybersecurity company specializing in endpoint security solutions. The firm develops advanced security technologies, including endpoint detection and response (EDR) and cloud workload protection platforms (CWPP), to safeguard users against emerging threats such as ransomware, advanced persistent threats (APT), and sophisticated Trojan horses. Majorsec's innovative approach includes adaptive micro-segmentation, which bolsters an organization’s capability to detect and respond to unknown vulnerabilities while maintaining control over the security status of hosts within the network. By focusing on enhancing user resilience against potential threats, Majorsec aims to provide comprehensive protection for enterprise environments.
Beijing BooCax Technology Co., Ltd. is a provider of advanced positioning and navigation solutions tailored for industrial mobile robots. The company specializes in developing robotic flexible collaboration systems and automated guided vehicle (AGV) products, focusing on enhancing the capabilities of robots within various operational environments. BooCax's technology plays a significant role in integrating indoor air management by enabling intelligent mobile robots to perform tasks such as disinfection and air quality improvement. Through its innovative approach, BooCax contributes to the advancement of robotics and automation in industrial settings.
DBSec is a reputable supplier of data security products, services, and solutions. They provide database encryption systems, database audit systems, cloud data security products, and holistic data security solutions. They serve the government, finance, social security, energy, military, operator, education, medical, and other industries.
ABAX Sensing
Venture Round in 2018
ABAX is developing an ultra-low cost, small form factor automotive grade Lidar solution based on Frequency-Modulated Continuous Waves. The company is headquartered in Xian (CN).
OnKure Therapeutics
Series A in 2018
OnKure Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of innovative cancer therapies. The company specializes in creating less toxic kinase inhibitor drugs and epigenetic therapies, including selective inhibitors of histone deacetylases. Its lead candidate, OKI-179, has demonstrated significant efficacy in preclinical models of hematological and solid tumor cancers, effectively reducing tumor growth both alone and in combination with other targeted therapies. Additionally, OnKure is advancing its HDAC3 selective inhibitor, OKI-422, into preclinical toxicology studies. The company's drug candidates are designed to directly target malignant cells, enhance the effects of small molecule therapies, and optimize the tumor microenvironment for improved checkpoint inhibition, addressing unmet medical needs in cancer treatment.
EcoFlow, established in 2016, is a pioneering company based in Shenzhen, China, with an additional office in San Francisco, California. It specializes in developing innovative, portable power solutions, including charging stations, backup generators, and emergency batteries. EcoFlow's products are designed for both indoor and outdoor use, offering multiple charging options such as solar, car, and wall chargers. They feature advanced technologies like temperature regulation, automatic power output adjustment, and individual port protection. EcoFlow sells its products online and through retail stores, with a mission to provide accessible, eco-friendly, and affordable power solutions, particularly in regions where power shortages hinder economic growth and development.
Reo Tech
Seed Round in 2018
Reo Tech is a manufacturing company that focuses on producing advanced electromagnetic technologies for military and industrial applications. The company develops a range of signal equipment designed for various communication purposes, specializing in electromagnetic environments and electronic countermeasures. Reo Tech's product offerings include signal playback devices, drone jamming systems, radar signal simulation tools, and transceiver modules. These products enable users to conduct sophisticated signal operations, utilizing cutting-edge technology to meet the demands of modern military and industrial communication needs.
Chance Pharmaceuticals
Series A in 2018
Chance Pharmaceuticals specializes in the discovery, development, and commercialization of inhalation therapies for treating debilitating diseases like chronic obstructive pulmonary disease (COPD), asthma, pulmonary arterial hypertension, and central nervous system disorders. The company focuses on creating generic drugs using innovative dry powder inhalation delivery systems, aiming to reduce manufacturing costs through advanced powder aerosol technology.
MicuRx Pharmaceuticals
Series D in 2017
MicuRx Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat drug-resistant bacterial infections. Founded in 2007 and based in Palo Alto, California, MicuRx operates with research and development facilities in both San Francisco, California, and Shanghai, China. The company's portfolio includes MRX-I, an oral antibiotic effective against multi-drug resistant gram-positive pathogens such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci; MRX-IV, a water-soluble prodrug form of MRX-I for intravenous use; MRX-V, an injectable antibiotic targeting gram-negative bacteria; and MRX-VIII, a polymyxin for gram-negative infections. Additionally, MicuRx's pipeline includes other antibacterial drugs designed to combat both gram-positive and gram-negative bacterial pathogens. The company employs a hybrid U.S./China business model, leveraging U.S. research and development with cost-efficient scientific resources in China. Shanghai MicuRx commercializes the agent contezolid in China, while global clinical studies are ongoing.
12 Sigma Technologies
Series B in 2017
12 Sigma Technologies, founded in April 2015, is an innovative healthcare company that focuses on modern medical image diagnosis and medical data analysis. The company leverages advanced artificial intelligence technology to enhance medical imaging applications, recognizing the significant potential at the intersection of AI and healthcare. It has established partnerships with General Electric to collaboratively develop smart diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, 12 Sigma has engaged with over 50 top-tier hospitals in China to facilitate applied medical diagnostics, technical research, and clinical trials, underscoring its commitment to advancing healthcare through cutting-edge technology.
UniZ is a technology startup based in San Diego, California, co-founded in February 2014 by a group of engineers. The company specializes in the development and distribution of high-performance 3D printing tools, primarily aimed at serving dental professionals and laboratories. UniZ's product offerings include advanced 3D printers, post-processing devices, and specialized printing materials tailored for the dental industry. By providing affordable and efficient solutions, UniZ enables its clients to enhance their operational efficiency and bring their creative visions to life.
Chance Pharmaceuticals
Angel Round in 2016
Chance Pharmaceuticals specializes in the discovery, development, and commercialization of inhalation therapies for treating debilitating diseases like chronic obstructive pulmonary disease (COPD), asthma, pulmonary arterial hypertension, and central nervous system disorders. The company focuses on creating generic drugs using innovative dry powder inhalation delivery systems, aiming to reduce manufacturing costs through advanced powder aerosol technology.
Zhongqu Technology
Angel Round in 2016
Zhongqu (Beijing) Technology Co., Ltd. is a company that specializes in the development of 3D scanning camera technology. Founded in 2014, it is located in Beijing, China. The company focuses on creating innovative solutions in the field of 3D scanning, catering to various applications and industries.
Weizhi Keji
Series A in 2015
Weizhi Keji is a market information consultation and investigation industry.
51 Dinghuo
Series A in 2015
Fengyun Network offers industrial internet services in the communications, pan-maternal, and infant industries, providing integrated services of commodity supply chain, scenario financial solutions, and digital technology to the upstream and downstream customers of the industry.
Chinaly New Materials
Venture Round in 2015
Chinaly New Materials focuses on the development, production, and marketing of lithium-ion battery separators.
HJIMI is a high-tech company that specializes in artificial intelligence with a focus on 3D computer vision, intelligent human-machine interaction, and 3D AR and MR technology. They serve retail, smart homes, consumer electronics, logistics, and other fields.
Nengdong Yingyu
Angel Round in 2014
Nengdong Yingyu is a learning and education platform. Active English has created a comprehensive set of scientific and rigorous curriculum systems to assist thousands of youngsters in learning English effortlessly and cheerfully. They provide services that include digital learning methods and products that include phonetic code, sentence rubik's cubes, and nine-nine syntax.
zhz tech
Venture Round in 2014
ZHZ Tech is an industrial company specializing in the development of aerial vehicles, including drones and helicopters. The company designs a diverse range of products that are capable of short-term flight and can be operated via remote control. These aerial vehicles serve various applications, catering to engineers and drone enthusiasts alike. ZHZ Tech's offerings include robotic drones utilized for tasks such as structural inspection, as well as for defense and surveillance purposes. The company focuses on innovation in the drone industry, aiming to meet the evolving needs of its customers.
Nanjng Yueboo Power System
Seed Round in 2014
Nanjing Yueboo Power System develops, manufactures, and sells automotive power systems.